State Ledger
Company profile

Sagimet Biosciences Inc. CIK 1400118

Ticker
SGMT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Foster City, CA 94404
Fiscal year end
2025 (FY)
Market Data
Close
$8.81
Change
-$0.12
Change %
-1.34%
Volume
47,907

SGMT · trading date Oct 12, 2026 · previous close $8.93 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$51.04M
Total assets
$116.48M
Total liabilities
—
Stockholders' equity
$111.38M
Cash & equivalents
$35.02M
Operating income
-$56.89M
Operating cash flow
-$45.65M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-11. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
95.6%
CapEx / revenue
—
Operating cash flow / net income
0.89×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$51.04M $116.48M — $111.38M
2024 — -$45.57M $160.26M — $155.81M
2023 $2.00M -$27.88M $96.72M $5.65M $91.07M
2022 — -$30.50M $33.03M $5.36M -$186.95M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-17
Financials filed via
Form 10-K
filed 2026-03-11

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Foster City, CA 94404
950 TOWER LANE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies